OIP — The Opportunity Intelligence PlatformOIP / Government Intelligence
Preparing the stored Government Intelligence discovery view.
OIP / Government Intelligence / Opportunity detail
Source: Stored live-derived Government dataNational Institutes of Health
OIP derived this review page from stored live-derived Government Intelligence source records. The official source and issuing agency remain authoritative.
Opportunity Intelligence Platform is an independent service and is not affiliated with or endorsed by the U.S. Government. Official notices, amendments, attachments, eligibility requirements, funding terms, and deadlines remain under source control.
OIP scores and explanations are informational and do not guarantee eligibility, suitability, compliance, contract award, or financial outcome.
No funding amount is disclosed in the stored source fields.
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education; Native American tribal organizations (other than Federally recognized tribal governments); Public and State controlled institutions of higher education; For profit organizations other than small businesses; County governments; Public housing authorities/Indian housing authorities; Small businesses; State governments; Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education; Special district governments; City or township governments; Native American tribal governments (Federally recognized); Independent school districts; Private institutions of higher education; Others (see text field entitled "Additional Information on Eligibility" for clarification)
2 warning(s) require review.
Objective score, derived by OIP
Publication decision: Publish with warning
Blueprint Neurotherapeutics Network (BPN): Biologic-based Drug Discovery and Development for Disorders of the Nervous System (UG3/UH3 Clinical Trial Optional) -- a Cooperative Agreement (Cooperative Agreement) issued by National Institutes of Health.
Objective Government score 67 for grants-gov-356610, computed from source evidence and Government scoring configuration.
potential_value (not_applicable): potential_value is structurally not applicable for this Government category.
10 evidence record(s) support this pipeline result.
Next action: Review the official Grants.gov opportunity and follow the listed application package instructions.
95/100 · Ok
evidence_quality scored from source evidence and Government scoring guidance (value kind deterministic_calculation, confidence rank 0).
90/100 · Ok
confidence scored from source evidence and Government scoring guidance (value kind rule_based_evaluation, confidence rank 1).
No numeric value · Not Applicable
potential_value is structurally not applicable for this Government category.
62/100 · Ok
urgency scored from source evidence and Government scoring guidance (value kind deterministic_calculation, confidence rank 0).
56/100 · Ok
difficulty scored from source evidence and Government scoring guidance (value kind rule_based_evaluation, confidence rank 1).
62/100 · Ok
time_required scored from source evidence and Government scoring guidance (value kind rule_based_evaluation, confidence rank 1).
48/100 · Ok
capital_required scored from source evidence and Government scoring guidance (value kind rule_based_evaluation, confidence rank 1).
52/100 · Ok
risk scored from source evidence and Government scoring guidance (value kind rule_based_evaluation, confidence rank 1).
68/100 · Ok
novelty scored from source evidence and Government scoring guidance (value kind rule_based_evaluation, confidence rank 1).
Blueprint Neurotherapeutics Network (BPN): Biologic-based Drug Discovery and Development for Disorders of the Nervous System (UG3/UH3 Clinical Trial Optional)
$.detail.opportunityTitle · Field Mapping · 98/100 confidence
356610 / PAR-24-293
$.detail.id · Field Mapping · 99/100 confidence
National Institutes of Health
$.detail.synopsis.agencyName · Field Mapping · 97/100 confidence
Cooperative Agreement
$.detail.synopsis.fundingInstruments · Field Mapping · 96/100 confidence
The Blueprint Neurotherapeutics Network for Biologics (BPN-Biologics) provides support for biologic-based therapeutic discovery and development, from lead optimization through phase I clinical testing. This Funding Opportunity Announcement (FOA) supports preclinical discovery and development of potential therapeutic Biotechnology Products and Biologics including, but not limited to, large biologic macromolecules, (e.g., proteins, antibodies, and peptides), gene-based therapies (i.e., oligonucleotide- and viral-based), cell therapies, and novel emerging therapies (e.g., microbial and microbiome therapies). Applicants will collaborate with NIH-funded consultants and can augment their project with NIH contract research organizations (CROs) that specialize in manufacturing, scaling, pharmacokinetics, toxicology, and Phase I clinical testing. BPN-Biologics awardee institutions retain their assignment of IP rights and gain assignment of IP rights from the BPN-Biologics contractors (and thereby control the patent prosecution and licensing negotiations) for biotherapeutic candidates developed in this program.
$.detail.synopsis.synopsisDesc · Field Mapping · 94/100 confidence
2024-10-01T04:00:00.000Z
$.detail.synopsis.postingDate · Field Mapping · 96/100 confidence
2027-08-18T00:00:00.000Z
$.searchHit.closeDate · Field Mapping · 92/100 confidence
Applicant types: Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education; Native American tribal organizations (other than Federally recognized tribal governments); Public and State controlled institutions of higher education; For profit organizations other than small businesses; County governments; Public housing authorities/Indian housing authorities; Small businesses; State governments; Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education; Special district governments; City or township governments; Native American tribal governments (Federally recognized); Independent school districts; Private institutions of higher education; Others (see text field entitled "Additional Information on Eligibility" for clarification)
Official source materials control eligibility, deadlines, amendments, attachments, and funding terms.
Open official source$.detail.synopsis.applicantTypes · Field Mapping · 94/100 confidence
value_not_disclosed
$.detail.synopsis · Field Mapping · 84/100 confidence
2024-10-01T18:43:15.000Z
$.detail.synopsis.lastUpdatedDate · Field Mapping · 88/100 confidence